Longevity Startups

FitnessGenes provides personalized health guidance based on DNA, blood, and wearable data to help people identify health risks early and take preventive action. The platform serves individuals seeking to extend healthy lifespan through data-driven insights grounded in genetic analysis.

1 investor

Five Alarm Bio develops pharmaceutical compounds targeting a novel aging mechanism to prevent and treat age-related chronic diseases. The company uses chemical synthesis and screening, along with cellular and animal models, to identify small molecules that restore cellular defense mechanisms against chemical damage associated with aging.

1 investor

Five Lives develops digital tools for Alzheimer's disease prevention and therapy, targeting the healthcare sector focused on cognitive decline and dementia management.

1 investor

Flow Nutrition manufactures dietary supplements, including Longevity 4.0, a formulated blend of natural substances designed to support cellular processes and slow aging. The company produces all products in-house in Jablonec nad Nisou, Czech Republic.

1 investor

For Youth sells longevity supplements aimed at reducing age-related cellular damage, marketed as a three-part "repair-protect-cleanse" system using ingredients like NMN, glutathione, and spermidine. Its products are formulated with input from longevity researchers and sold to consumers in over 30 countries.

1 investor

Founders Health is a doctor-led clinic that combines advanced diagnostics, functional medicine, and regenerative approaches to build personalized health strategies for long-term health, performance, and recovery. It offers coordinated care focused on longevity, cognitive performance, hormonal and metabolic balance, and physical resilience.

1 investor

Foundry BioSciences develops protein language models powered by AI for protein engineering to address aging and longevity. The company serves users, partners, and patients globally through novel protein sequences.

1 investor

FutureYou Cambridge develops scientifically-backed nutritional supplements for consumer health and wellness, with formulations optimized for absorption and supported by published clinical research. The company operates through multiple brands including its flagship line, Prime Fifty for over-50s nutrition, and GP Nutrition for beauty and longevity supplements.

1 investor

Gaia Life is developing whole ovary banking aimed at preserving women's natural fertility and hormone balance, with the goal of extending reproductive years, health, and vitality. The company operates in the women's reproductive health and fertility space.

1 investor

Gamida Cell develops cell therapy treatments designed to expand and enhance cells for therapeutic applications. The company focuses on delivering potentially curative therapies to patients with unmet medical needs.

1 investor

General Biotechnologies manufactures peptide therapeutics by genetically programming edible microbes to synthesise molecules, aiming to produce them at lower cost. It focuses on reviving clinically proven but discontinued off-patent peptides as low-cost oral drugs, including an oral GLP-1, and partners with pharma companies to bring shelved assets back as oral formulations.

1 investor

Geoffrey Woo is a founder and investor focused on human performance, organizational excellence, and software automation. He is co-founder of Ketone-IQ (a nutritional supplement company) and Archive (a software automation platform for social and e-commerce), managing partner of Anti Fund (a venture capital firm), and board director at W and Betr.

1 investor

Gero is a biotech company applying AI, data science, and physics-based models of human health to discover drug targets and therapies for aging and age-related chronic diseases. It develops a therapeutic pipeline using longitudinal health data, statistical genetics, and multi-omics.

1 investor

Glyscend Therapeutics is a clinical-stage biopharmaceutical company developing oral, first-in-class therapies for type 2 diabetes and obesity. Its approach originated from research on how certain bariatric surgeries improve glucose and metabolic regulation and produce sustained weight loss.

1 investor

GoGoGrandparent is a concierge service that lets older adults arrange rides, meal and grocery delivery, medication, and home maintenance through a regular phone call without needing special technology. It targets seniors living independently at home, coordinating vetted service providers and monitoring requests for reliability.

1 investor

Groq Health is a consumer health app that uses AI to analyze a person's health history, biomarkers, wearable data, and DNA to prescribe personalized treatments aimed at reversing signs of aging and preventing disease. It targets individuals seeking longevity and preventive care through precision diagnostics and tailored interventions.

1 investor

Gutcrine is a Danish biotech developing pharmabiotics derived from gut microbiome hormone synthesis, aimed at the prevention and treatment of cardio-metabolic disorders.

1 investor

HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics as first-in-class immunotherapies for autoimmune diseases, cancer, and senescence-associated dysplasia. It uses proprietary drug discovery platforms to create multi-specific cytokines, targeted immune checkpoint inhibitors, and immune-cell engagers, with lead candidates in commercial and clinical stages.

1 investor

Longevity Health Holdings develops products focused on longevity, healthy aging, and regenerative bio-aesthetics, including skincare and cosmetics lines. Its consumer brands aim to help people look and feel their best at any age.

1 investor

A clinic offering personalized longevity medicine programs designed to extend healthspan through scientifically-proven interventions, combining advanced diagnostics and therapies sourced from cutting-edge research. The clinic serves individuals seeking to optimize their health and quality of life across all ages through comprehensive, systematic, and long-term personalized health protocols.

1 investor

Healz analyzes up to 100 advanced biomarkers across 8 specialized panels to identify biological causes of symptoms like fatigue, brain fog, weight changes, and low performance, providing clinical interpretation and a 30-day action plan. It serves both individuals and companies, offering an anonymized corporate dashboard for workforce health, with CE IVDR certification and a focus on the European market.

1 investor

Hemostemix is a clinical-stage regenerative medicine company developing ACP-01, an investigational autologous (patient-derived) stem cell therapy for vascular and ischemic conditions such as critical limb ischemia, peripheral arterial disease, ischemic cardiomyopathy, and heart failure. The company runs Phase I and Phase II clinical programs and is publicly traded (TSXV: HEM | OTCQB: HMTXF).

1 investor

Holaglow operates aesthetic medicine clinics offering aesthetic medicine, advanced aesthetics, cosmetic surgery, and longevity treatments applied by professionals. It runs its own clinics in 7 cities in Spain and provides personalized advice, financing options, and post-treatment care.

1 investor

Holobiome discovers and develops therapies and next-generation probiotics derived from the human gut microbiome, aiming to address whole-body health challenges. The company applies microbiome science to create first-in-class treatments and targeted health solutions.

1 investor